UTILIZACION DE PLANTAS DEL GENERO SIDERITIS Y EXTRACTOS OBTENIDOS A PARTIR DE ELLAS PARA EL TRATAMIENTO DEL SINDROME DE DEFICIT DE ATENCION CON HIPERACTIVIDAD

UTILIZACION DE PLANTAS DEL GENERO SIDERITIS Y EXTRACTOS OBTENIDOS A PARTIR DE ELLAS PARA EL TRATAMIENTO DEL SINDROME DE DEFICIT DE ATENCION CON HIPERACTIVIDAD

Plantas del genero Sideritis y/o partes de estas plantas y/o extractos de estas plantas y/o partes de plantas para la utilización en el tratamiento del síndrome de déficit de atención con hiperactividad. Use of Sideritisplants, parts of these plants, extracts from this plants and/or plant parts for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SCHNIERLE, PETER, KNOERLE, RAINER
Format: Patent
Sprache:spa
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SCHNIERLE, PETER
KNOERLE, RAINER
description Plantas del genero Sideritis y/o partes de estas plantas y/o extractos de estas plantas y/o partes de plantas para la utilización en el tratamiento del síndrome de déficit de atención con hiperactividad. Use of Sideritisplants, parts of these plants, extracts from this plants and/or plant parts for the manufacture of a drug for treatment of attention deficit hyperactivity syndrome. ACTIVITY : Nootropic; Tranquilizer. MECHANISM OF ACTION : Noradrenaline reuptake inhibitor; Dopamine reuptake inhibitors. The ability of the extract to inhibit dopamine reuptake was tested on rat brain homogenate, where the results were compared with methylphenidate which showed the EC50 value of 0.9 mu M.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2368689TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2368689TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2368689TT33</originalsourceid><addsrcrecordid>eNqNjU0KAjEMhWfjQtQ7xAO4cWDQZWwzTqDTDm0UdSMidSUq6Hk8qxnxAC5CvgfvZ1i8N8KOD2g4eLAEnUMvmBQdrMlTDJDYUmThBHugnUQ0EhKElZBnq4TQYRSOfZyc07BqVAT1CrZMXsK3MLG3MbTUOy3VbFh6RG367hu9hjvqJ3jLFu24GFxO12ee_P6omNYkppnlx_2Yn4_TOd_y60hpXlaLarEUKct_PB-vmkRg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>UTILIZACION DE PLANTAS DEL GENERO SIDERITIS Y EXTRACTOS OBTENIDOS A PARTIR DE ELLAS PARA EL TRATAMIENTO DEL SINDROME DE DEFICIT DE ATENCION CON HIPERACTIVIDAD</title><source>esp@cenet</source><creator>SCHNIERLE, PETER ; KNOERLE, RAINER</creator><creatorcontrib>SCHNIERLE, PETER ; KNOERLE, RAINER</creatorcontrib><description>Plantas del genero Sideritis y/o partes de estas plantas y/o extractos de estas plantas y/o partes de plantas para la utilización en el tratamiento del síndrome de déficit de atención con hiperactividad. Use of Sideritisplants, parts of these plants, extracts from this plants and/or plant parts for the manufacture of a drug for treatment of attention deficit hyperactivity syndrome. ACTIVITY : Nootropic; Tranquilizer. MECHANISM OF ACTION : Noradrenaline reuptake inhibitor; Dopamine reuptake inhibitors. The ability of the extract to inhibit dopamine reuptake was tested on rat brain homogenate, where the results were compared with methylphenidate which showed the EC50 value of 0.9 mu M.</description><language>spa</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20111121&amp;DB=EPODOC&amp;CC=ES&amp;NR=2368689T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20111121&amp;DB=EPODOC&amp;CC=ES&amp;NR=2368689T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SCHNIERLE, PETER</creatorcontrib><creatorcontrib>KNOERLE, RAINER</creatorcontrib><title>UTILIZACION DE PLANTAS DEL GENERO SIDERITIS Y EXTRACTOS OBTENIDOS A PARTIR DE ELLAS PARA EL TRATAMIENTO DEL SINDROME DE DEFICIT DE ATENCION CON HIPERACTIVIDAD</title><description>Plantas del genero Sideritis y/o partes de estas plantas y/o extractos de estas plantas y/o partes de plantas para la utilización en el tratamiento del síndrome de déficit de atención con hiperactividad. Use of Sideritisplants, parts of these plants, extracts from this plants and/or plant parts for the manufacture of a drug for treatment of attention deficit hyperactivity syndrome. ACTIVITY : Nootropic; Tranquilizer. MECHANISM OF ACTION : Noradrenaline reuptake inhibitor; Dopamine reuptake inhibitors. The ability of the extract to inhibit dopamine reuptake was tested on rat brain homogenate, where the results were compared with methylphenidate which showed the EC50 value of 0.9 mu M.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjU0KAjEMhWfjQtQ7xAO4cWDQZWwzTqDTDm0UdSMidSUq6Hk8qxnxAC5CvgfvZ1i8N8KOD2g4eLAEnUMvmBQdrMlTDJDYUmThBHugnUQ0EhKElZBnq4TQYRSOfZyc07BqVAT1CrZMXsK3MLG3MbTUOy3VbFh6RG367hu9hjvqJ3jLFu24GFxO12ee_P6omNYkppnlx_2Yn4_TOd_y60hpXlaLarEUKct_PB-vmkRg</recordid><startdate>20111121</startdate><enddate>20111121</enddate><creator>SCHNIERLE, PETER</creator><creator>KNOERLE, RAINER</creator><scope>EVB</scope></search><sort><creationdate>20111121</creationdate><title>UTILIZACION DE PLANTAS DEL GENERO SIDERITIS Y EXTRACTOS OBTENIDOS A PARTIR DE ELLAS PARA EL TRATAMIENTO DEL SINDROME DE DEFICIT DE ATENCION CON HIPERACTIVIDAD</title><author>SCHNIERLE, PETER ; KNOERLE, RAINER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2368689TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2011</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SCHNIERLE, PETER</creatorcontrib><creatorcontrib>KNOERLE, RAINER</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SCHNIERLE, PETER</au><au>KNOERLE, RAINER</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>UTILIZACION DE PLANTAS DEL GENERO SIDERITIS Y EXTRACTOS OBTENIDOS A PARTIR DE ELLAS PARA EL TRATAMIENTO DEL SINDROME DE DEFICIT DE ATENCION CON HIPERACTIVIDAD</title><date>2011-11-21</date><risdate>2011</risdate><abstract>Plantas del genero Sideritis y/o partes de estas plantas y/o extractos de estas plantas y/o partes de plantas para la utilización en el tratamiento del síndrome de déficit de atención con hiperactividad. Use of Sideritisplants, parts of these plants, extracts from this plants and/or plant parts for the manufacture of a drug for treatment of attention deficit hyperactivity syndrome. ACTIVITY : Nootropic; Tranquilizer. MECHANISM OF ACTION : Noradrenaline reuptake inhibitor; Dopamine reuptake inhibitors. The ability of the extract to inhibit dopamine reuptake was tested on rat brain homogenate, where the results were compared with methylphenidate which showed the EC50 value of 0.9 mu M.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language spa
recordid cdi_epo_espacenet_ES2368689TT3
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title UTILIZACION DE PLANTAS DEL GENERO SIDERITIS Y EXTRACTOS OBTENIDOS A PARTIR DE ELLAS PARA EL TRATAMIENTO DEL SINDROME DE DEFICIT DE ATENCION CON HIPERACTIVIDAD
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T18%3A31%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SCHNIERLE,%20PETER&rft.date=2011-11-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2368689TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true